Product Information
Registration Status: ActiveSIN11825P
CERETEC FOR INJECTION 0.5mg/VIAL is approved to be sold in Singapore with effective from 2002-02-28. It is marketed by GE HEALTHCARE PTE LTD, with the registration number of SIN11825P.
This product contains Exametazime 0.5mg/vial in the form of INJECTION, POWDER, FOR SOLUTION. It is approved for INTRAVENOUS use.
This product is manufactured by GE HEALTHCARE AS (OSLO SITE) in NORWAY.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Description
Exametazime is a diagnostic radiopharmaceutical agent commonly used for the preparation of Tc99m Exametazime injection. It acts as a chelating agent for the radioisotope technetium-99m to form a cationic complex. It is used in the detection of altered regional cerebral perfusion and for the radiolabeling of autologous leukocytes.
Active Ingredient/Synonyms
Exametazime | Exametazime |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.